Back to search

Article

Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation – A Short Review

2025-03-10

Abstract excerpt

Sickle cell disease (SCD) is a monogenic blood disorder characterized by abnormal hemoglobin S production, which polymerizes under hypoxia conditions to produce chronic hemolysis, widespread organ damage, and vasculopathy. As a result of vaso-occlusion and ischemia-reperfusion injury, individuals with SCD have recurrent pain episodes, infection, pulmonary disease and fall victim to early death. Oxidative stress du...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a78ac119-7e11-5548-8405-940b7ae66b2b
DOI
10.20944/preprints202503.0572.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation – A Short ReviewDOI 10.20944/preprints202503.0572.v1
Select a neighboring publication to make it the new centre.